# Women's Hormone Health Programs Ivim Health Builds a Platform Around HormoneIQ™ By Kalin Ned | Published 2026-07-22 | Lifestyle Source: Trend Hunter, https://www.trendhunter.com/trends/womens-hormone-health-program References: [prnewswire](https://www.prnewswire.com/news-releases/ivim-health-launches-hormoneiq-treating-a-womans-hormone-symptoms-as-clinical-data-302800793.html)  Ivim Health, a physician-led virtual medical practice operating across all 50 states, has launched a comprehensive women's hormone health [program](https://www.trendhunter.com/trends/touchtoe) built around HormoneIQ™. This proprietary assessment tool scores symptoms across six domains — vasomotor symptoms, sleep and energy, mood, cognition, sexual wellness, and body composition — to guide individualized treatment plans and track progress over time. Ivim Health's women's hormone health program also introduces HypoSpray, a transdermal estradiol formulation designed to provide continuity of care for patients affected by the national estrogen patch shortage. HormoneIQ™ was developed by Dr. Jessica Duncan and Dr. Taylor Kantor based on the clinical recognition that fluctuating hormone levels during perimenopause often appear normal in standard blood tests. According to the brand, this makes a woman's reported experience of her own body the most meaningful clinical data for guiding treatment. Image Credit: Plexus Worldwide ## Trend Insights (Trend Hunter) - Score: 6.5/10 - Popularity: 59% | Activity: 52% | Freshness: 84% - Audience gender: 10% men, 90% women - Primary generations: Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Lifestyle](https://www.trendhunter.com/lifestyle) > [Health](https://www.trendhunter.com/health) ## Key Themes ### What's Driving This Trend - **Symptom-based Diagnostics:** Patient-reported symptom scoring is becoming a data layer for personalized care when conventional lab markers fail to capture fluctuating health conditions. - **Virtual Menopause Care:** Telehealth platforms are expanding into midlife women’s health by combining clinical access, longitudinal tracking, and condition-specific treatment pathways. - **Hormone Delivery Alternatives:** Supply disruptions in established therapies are creating space for new transdermal formats that support continuity and convenience in hormone treatment. ### Who This Affects Most - **Digital Health:** Proprietary assessment tools embedded in virtual care models can differentiate platforms through personalized monitoring and scalable specialty services. - **Women’s Health:** Greater recognition of perimenopause and hormone-related symptoms is opening underserved categories for clinically guided, experience-centered care solutions. - **Pharmaceuticals:** Alternative estrogen formulations highlight opportunities for drug delivery innovation tied to access challenges, adherence, and patient preference. ## Related on Trend Hunter - [Expanded Diagnostic Platforms](https://www.trendhunter.com/trends/diagnostic-platforms.md) - [AI Menopause Platforms](https://www.trendhunter.com/trends/amissa.md) - [Women-Focused Health Programs](https://www.trendhunter.com/trends/womens-health-awareness-program.md) - [Prescription-Strength Midlife Skincare](https://www.trendhunter.com/trends/midi-health-skincare.md) - [Hormone-Focused Metabolic Supplements](https://www.trendhunter.com/trends/metabolic-control.md) - [Women-Focused Testosterone Therapies](https://www.trendhunter.com/trends/joi-blokes.md) - [Menopausal Data-Driven Reports](https://www.trendhunter.com/trends/perimenopause-and-menopause.md) - [Women’s Testosterone Therapies](https://www.trendhunter.com/trends/womens-testosterone-therapy.md) - [Education-Focused Brand Advocacy Initiatives](https://www.trendhunter.com/trends/hormonal-health-education.md)